ArticleBrain, behavior, and immunity2026
Diagnosis of depression in adolescence signals improved inflammatory health in adulthood: Results from a nationally representative longitudinal study.
Article in Brain, behavior, and immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectiveChildhood maltreatment increases subsequent risk for major depressive disorder (MDD), potentially through inflammatory pathways. The timely diagnosis and treatment of MDD may thus interrupt the association between inflammation and depressive symptoms, but diagnosis is frequently delayed. Additionally, sex-differences may affect timely diagnosis and treatment, contributing to differences in inflammation and depressive symptoms as individuals age.
methodWe used data from the nationally representative National Longitudinal Study of Adolescent to Adult Health to examine how diagnosis of MDD in adolescence vs. adulthood affected associations between childhood maltreatment, C-reactive protein (CRP) levels, and depressive symptoms in adulthood. We used path analysis to examine associations between these variables and then tested for sex differences by moderating pathways by sex.
resultsChildhood maltreatment increased the risk of being diagnosed with MDD at any time, and being diagnosed with MDD was associated with greater depressive symptoms in adulthood. Diagnosis of MDD at any time was associated with greater depressive symptoms, but diagnosis of MDD in adolescence was associated with lower CRP levels relative to diagnosis in adulthood. Sex differences analysis indicated that CRP was greatest for males diagnosed in adulthood despite females being diagnosed in adulthood having a greater body mass index.
conclusionThese data demonstrate that diagnosing MDD in adolescence was associated with better inflammatory health in adulthood. Diagnosing and treating depression sooner after symptom onset may thus improve overall prognosis, particularly for males, and potentially reduce the risk for other inflammation-related conditions as well.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.